{
    "2020-05-29": [
        [
            {
                "time": "2020-05-29",
                "original_text": "王晶翼获科伦千万股权激励，本土药企为留人才放大招！恒瑞、信达、基石……谁的激励更丰厚？",
                "features": {
                    "keywords": [
                        "股权激励",
                        "科伦",
                        "恒瑞",
                        "信达",
                        "基石"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "1万年薪却能得9亿分红？299家A股药企高管薪酬大揭秘！迈瑞、药明争抢榜首，恒瑞仍保持低调",
                "features": {
                    "keywords": [
                        "高管薪酬",
                        "迈瑞",
                        "药明",
                        "恒瑞"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "金徽酒易主复星系 “西北王”有望加速布局全国市场？控制人变化",
                "features": {
                    "keywords": [
                        "金徽酒",
                        "复星系",
                        "控制人变化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "复星医药旗下抗恶性肿瘤新药获美FDA临床试验批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "FDA",
                        "临床试验",
                        "新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "恒指跌0.73%报22964.15点汽车板块领跌",
                "features": {
                    "keywords": [
                        "恒指",
                        "汽车板块",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "指数",
                        "汽车"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "中生制药绩后倒升逾8%冠蓝筹 获瑞信升至跑赢大市",
                "features": {
                    "keywords": [
                        "中生制药",
                        "瑞信",
                        "跑赢大市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "郭广昌再度“喝酒” 复星系加速白酒布局",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "复星系",
                        "白酒"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}